Wealth Enhancement Advisory Services LLC bought a new stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 11,335 shares of the company's stock, valued at approximately $753,000.
A number of other hedge funds have also bought and sold shares of the business. GAMMA Investing LLC boosted its holdings in shares of Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company's stock worth $35,000 after purchasing an additional 297 shares in the last quarter. Crewe Advisors LLC purchased a new position in shares of Ryan Specialty in the 2nd quarter worth about $39,000. Rothschild Investment LLC purchased a new position in shares of Ryan Specialty in the 2nd quarter worth about $87,000. Signaturefd LLC lifted its stake in shares of Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company's stock valued at $89,000 after acquiring an additional 148 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its stake in shares of Ryan Specialty by 1,688.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,844 shares of the company's stock valued at $165,000 after acquiring an additional 2,685 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
RYAN has been the subject of a number of recent research reports. UBS Group boosted their target price on Ryan Specialty from $67.00 to $76.00 and gave the company a "buy" rating in a research note on Tuesday, August 13th. Bank of America increased their price objective on Ryan Specialty from $75.00 to $84.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. JPMorgan Chase & Co. increased their price objective on Ryan Specialty from $54.00 to $56.00 and gave the stock an "underweight" rating in a report on Friday, August 2nd. BMO Capital Markets upgraded Ryan Specialty from a "market perform" rating to an "outperform" rating and raised their target price for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. Finally, The Goldman Sachs Group raised their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a research note on Wednesday, October 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $70.33.
Read Our Latest Report on RYAN
Insider Activity
In related news, Director Nicholas Dominic Cortezi sold 1,500 shares of the business's stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $65.02, for a total value of $97,530.00. Following the sale, the director now directly owns 25,123 shares in the company, valued at approximately $1,633,497.46. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, President Timothy William Turner sold 2,000,000 shares of the stock in a transaction on Friday, August 9th. The stock was sold at an average price of $62.45, for a total transaction of $124,900,000.00. Following the completion of the sale, the president now owns 8,095 shares in the company, valued at approximately $505,532.75. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 1,500 shares of the company's stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $65.02, for a total value of $97,530.00. Following the completion of the transaction, the director now directly owns 25,123 shares in the company, valued at approximately $1,633,497.46. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 2,107,136 shares of company stock worth $131,860,032 over the last ninety days. Corporate insiders own 11.10% of the company's stock.
Ryan Specialty Stock Up 3.2 %
Shares of Ryan Specialty stock traded up $2.19 on Thursday, reaching $71.14. The company's stock had a trading volume of 806,529 shares, compared to its average volume of 880,265. The company has a market capitalization of $18.63 billion, a price-to-earnings ratio of 89.51, a P/E/G ratio of 1.52 and a beta of 0.62. The firm's fifty day simple moving average is $67.30 and its two-hundred day simple moving average is $60.86. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $73.10. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. The company had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty's revenue was up 20.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.32 earnings per share. Equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.81 earnings per share for the current year.
Ryan Specialty Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be given a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.62%. Ryan Specialty's payout ratio is 57.14%.
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.